Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/132021
Title: EPG5-related Vici syndrome : a paradigm of neurodevelopmental disorders with defective autophagy
Authors: Byrne, Susan
Jansen, Lara
U-King-Im, Jean-Marie
Siddiqui, Ata
Lidov, Hart G.W.
Bodi, Istvan
Smith, Luke
Mein, Rachael
Cullup, Thomas
Dionisi-Vici, Carlo
AlGazali, Lihadh
Al-Owain, Mohammed
Bruwer, Zandre
Al Thihli, Khalid
El-Garhy, Rana
Flanigan, Kevin M.
Manickam, Kandamurugu
Zmuda, Erik
Banks, Wesley
Gershoni-Baruch, Ruth
Mandel, Hanna
Dagan, Efrat
Raas-Rothschild, Annick
Barash, Hila
Filloux, Francis
Creel, Donnell
Harris, Michael
Hamosh, Ada
Kolker, Stefan
Ebrahimi-Fakhari, Darius
Hoffmann, Georg F.
Manchester, David
Boyer, Philip J.
Manzur, Adnan Y.
Marques Lourenco, Charles
Pilz, Daniela T.
Kamath, Arveen
Prabhakar, Prab
Rao, Vamshi K.
Curtis Rogers, R.
Ryan, Monique M.
Brown, Natasha J.
McLean, Catriona A.
Said, Edith
Schara, Ulrike
Stein, Anja
Sewry, Caroline
Travan, Laura
Wijburg, Frits A.
Zenker, Martin
Mohammed, Shehla
Fanto, Manolis
Gautel, Mathias
Jungbluth, Heinz
Keywords: Nervous system -- Diseases
Autophagy-related proteins
Autophagy-related protein 5
Neurodevelopmental treatment
Nervous system -- Degeneration
Issue Date: 2016
Publisher: Oxford University Press
Citation: Byrne, S., Jansen, L., U-King-Im, J. M., Siddiqui, A., Lidov, H. G., Bodi, I.,...Jungbluth, H. (2016). EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy. Brain, 139(3), 765-781.
Abstract: Vici syndrome is a progressive neurodevelopmental multisystem disorder due to recessive mutations in the key autophagy gene EPG5. We report genetic, clinical, neuroradiological, and neuropathological features of 50 children from 30 families, as well as the neuronal phenotype of EPG5 knock-down in Drosophila melanogaster. We identified 39 different EPG5 mutations, most of them truncating and predicted to result in reduced EPG5 protein. Most mutations were private, but three recurrent mutations (p.Met2242Cysfs*5, p.Arg417*, and p.Gln336Arg) indicated possible founder effects. Presentation was mainly neonatal, with marked hypotonia and feeding difficulties. In addition to the five principal features (callosal agenesis, cataracts, hypopigmentation, cardiomyopathy, and immune dysfunction), we identified three equally consistent features (profound developmental delay, progressive microcephaly, and failure to thrive). The manifestation of all eight of these features has a specificity of 97%, and a sensitivity of 89% for the presence of an EPG5 mutation and will allow informed decisions about genetic testing. Clinical progression was relentless and many children died in infancy. Survival analysis demonstrated a median survival time of 24 months (95% confidence interval 0–49 months), with only a 10th of patients surviving to 5 years of age. Survival outcomes were significantly better in patients with compound heterozygous mutations (P = 0.046), as well as in patients with the recurrent p.Gln336Arg mutation. Acquired microcephaly and regression of skills in long-term survivors suggests a neurodegenerative component superimposed on the principal neurodevelopmental defect. Two-thirds of patients had a severe seizure disorder, placing EPG5 within the rapidly expanding group of genes associated with early-onset epileptic encephalopathies. Consistent neuroradiological features comprised structural abnormalities, in particular callosal agenesis and pontine hypoplasia, delayed myelination and, less frequently, thalamic signal intensity changes evolving over time. Typical muscle biopsy features included fibre size variability, central/internal nuclei, abnormal glycogen storage, presence of autophagic vacuoles and secondary mitochondrial abnormalities. Nerve biopsy performed in one case revealed subtotal absence of myelinated axons. Post-mortem examinations in three patients confirmed neurodevelopmental and neurodegenerative features and multisystem involvement. Finally, downregulation of epg5 (CG14299) in Drosophila resulted in autophagic abnormalities and progressive neurodegeneration. We conclude that EPG5-related Vici syndrome defines a novel group of neurodevelopmental disorders that should be considered in patients with suggestive features in whom mitochondrial, glycogen, or lysosomal storage disorders have been excluded. Neurological progression over time indicates an intriguing link between neurodevelopment and neurodegeneration, also supported by neurodegenerative features in epg5-deficient Drosophila, and recent implication of other autophagy regulators in late-onset neurodegenerative disease.
URI: https://www.um.edu.mt/library/oar/handle/123456789/132021
Appears in Collections:Scholarly Works - FacM&SAna

Files in This Item:
File Description SizeFormat 
EPG5_related_vici_syndrome.pdf1.89 MBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.